Abstract
In cyclosporine-treated cardiac allograft recipients, rejection and infection are two principal early complications. The following report describes our approach to the diagnosis and management of rejection. Infectious complications are discussed elsewhere in this journal. Lymphoproliferative disorders have not been reported in our series of transplant recipients. Other early complications particularly related to cyclosporine immuno-suppressive therapy include systemic hypertension, renal insufficiency, hepatic toxicity, and pancreatitis. Each of these is illustrated by a representative group or patient profile. (Texas Heart Institute Journal 1987; 14:257-261)
Keywords: Heart/transplantation
Keywords: immunosuppressive therapy
Keywords: cyclosporine
Keywords: hypertension
Keywords: renal insufficiency
Keywords: hepatic toxicity
Keywords: pancreatitis
Full text
PDF
